Alzheimer's Disease: Part 2 - A Botanical Treatment Plan

Alternative and Complementary Therapies

Volumn 10, Issue 2, 2004, Pages 67-72

  Abascal, Kathy ^a   Yarnell, Eric ^a,b  

^a Botanical Medicine Academy   (United States)

^b BASTYR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLINESTERASE INHIBITOR; CURCUMA LONGA EXTRACT; DIHYDROERGOTOXINE MESILATE; GINKGO BILOBA EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; ROSMARINUS OFFICINALIS EXTRACT; SALVIA OFFICINALIS EXTRACT; WITHANIA SOMNIFERA EXTRACT;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; CHINESE MEDICINE; DIET SUPPLEMENTATION; DIETARY INTAKE; DIZZINESS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEART PALPITATION; HUMAN; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; PEPTIC ULCER; REPRODUCTIVE TOXICITY; REVIEW; STOMACH DISEASE; SUBDURAL HEMATOMA; TREATMENT PLANNING; VOMITING;

EID: 16544382855     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/107628004773933299     Document Type: Review

References (36)

1. Schulz V. Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trials and guidelines fail to consider. Phytomed 2003;10(supplIV):74-79.
2. Birks J, Grimley E, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2002;4:CD003120.
3. Van Dongen M, Van Rossum E, Kessels A, et al. Ginkgo for elderly people with dementia and age-associated memory impairment: A randomized clinical trial. J Clin Epidemiol 2003;56(4):367-376.
4. Koepp R, Miles SH, Qizilbash N, Schneider L, Farlow M, Whitehead A, Higgins J. Meta-analysis of tacrine for Alzheimer disease: The influence of industry sponsors [7 letters]. JAMA 1999;281:2287-2288.
5. Sierpina VS, Wollschlaeger B, Blumenthal M. Ginkgo biloba. Am Fam Physician 2003;68:923-926.
6. Ganguli M, Chandra V, Kamboh MI, et al. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-U.S. cross-nutritional dementia study. Arch Neurol 2000;57:824-830.
7. Breitner JCS, Welsh KA, Helms MJ, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-530.
8. Banerjee M, Tripathi LM, Srivastava VML, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003;25:213-224.
9. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa). J Altern Complement Med 2003;9:161-168.
10. Van Dau N, Ngoc Ham N, Huy Khac D, et al. The effects of a traditional drug, turmeric (Curcuma longa), and placebo on the healing of duodenal ulcer. Phytomedicine 1998;5:29-34.
11. Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001;21:8370-8377.
12. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 2002;46:273-279.
13. Butterfield DA, Castegna A, Pocernich CB, et al. Nutritional approaches to combat oxidative stress in Alzheimer's disease. J Nutr Biochem 2002;13:444-461.
14. Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001;21:8370-8377.
15. Caughey B, Raymond LD, Raymond GJ, et al. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 2003;77:5499-5502.
16. Yarnell E, Abascal K, Hooper CG. Clinical Botanical Medicine. Larchmont, NY: Mary Ann Liebert, Inc. 2003.
17. Kennedy DO, Scholey AB, Tildesley NTJ, et al. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol, Biochem Behav 2002;72:952-964.
18. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized, placebo controlled trial. J Neurol Neurosurg Psychiatry 2003;74:863-866.
19. Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychology 2002;63:553-558.
20. Perry NSL, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003;75:651-659.
21. Tildesley NTJ, Kennedy DO, Perry EK, et al. Salvia lavendufolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav 2003;75:669-674.
22. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003;28:53-59.
23. The vaults of Erowid. Online document at: www.erowid.org/chemi cals/absinthe/absinthe_info3.shtml November 2003.
24. Elbetieha A, Al-Hamoood MH, Alkofahi A, Bataineh H. Reproductive toxicity potentials of Salvia fruticosa (Labiatae) in rats. J Ethnopharmacol 1998;61:67-74.
25. Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 2003;113:15-38.
26. Aruoma OI, Spencer JPE, Rossi R, et al. An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provencal herbs. Food Chem Toxicol 1996;34:449-56.
27. Dr. James Duke's Phytochemical Database. Online document at www.ars-grin.gov/duke/ November 2003.
28. Abascal K, Yarnell E. Increasing vitality with adaptogens: Multifaceted herbs for treating physical and mental stress. Altern Complement Ther 2003;9:54-60.
29. Kubyoyama T, Tohda C, Zhao J, et al. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport 2002;13:1715-1720.
30. Mishra L-C, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A review. Alt Med Rev 2000; 5:334-346.
31. Kennedy DO, Scholey AB. Ginseng: Potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003;75:687-700.
32. Butterfield DA, Castegna A, Pocernich CB, et al. Nutritional approaches to combat oxidative stress in Alzheimer's disease. J Nutr Biochem 2002;13(8):444-461.
33. 2 receptors correlate with memory functions in Alzheimer's disease. Eur J Neurosci 2003;18:149-154.
34. Skoog I, Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neur Res 2003;25:675-680.
35. Aronow WS. Homocysteine: The association with atherosclerotic vascular disease in older persons. Geriatrics 2003;58:22-28.
36. Steenge GR, Verhoef P, Katan-Martijn B. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 2003;133:1291-1295.